BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹127 Cr | ₹151 Cr | ₹117 Cr | ₹118 Cr | ₹107 Cr |
What is the latest Operating Profit of BLISS GVS PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹127 Cr |
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹118 Cr |
| Mar2022 | ₹107 Cr |
How is Operating Profit of BLISS GVS PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹127 Cr | -15.89 | |
| Mar2025 | ₹151 Cr | 28.38 | |
| Mar2024 | ₹117 Cr | -0.86 | |
| Mar2023 | ₹118 Cr | 10.97 | |
| Mar2022 | ₹107 Cr | - | |
Compare Operating Profit of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹6,687.2 Cr | -4.6% | -9% | 319.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -4.6% |
-9% |
319.4% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses